{"id":560846,"date":"2026-07-04T02:00:00","date_gmt":"2026-07-04T00:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/terapias-orais-com-glp-1-attain-1-e-oasis-4-o-proximo-passo\/"},"modified":"2026-07-10T17:58:36","modified_gmt":"2026-07-10T15:58:36","slug":"terapias-orais-com-glp-1-attain-1-e-oasis-4-o-proximo-passo","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/terapias-orais-com-glp-1-attain-1-e-oasis-4-o-proximo-passo\/","title":{"rendered":"Terapias orais com GLP-1: ATTAIN-1 e OASIS-4 \u2013 o pr\u00f3ximo passo"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Os agonistas injet\u00e1veis do recetor do GLP-1 e o agonista duplo GIP\/GLP-1 tirzepatida redefiniram o tratamento farmacol\u00f3gico da obesidade e alcan\u00e7aram, em estudos, redu\u00e7\u00f5es de peso da ordem dos 15 a 20%. No entanto, a sua aplica\u00e7\u00e3o na pr\u00e1tica continua a ser limitada \u2014 devido \u00e0 pr\u00f3pria inje\u00e7\u00e3o, aos custos, aos requisitos da cadeia de frio, aos estrangulamentos no abastecimento e a uma ades\u00e3o terap\u00eautica frequentemente insatisfat\u00f3ria. A Organiza\u00e7\u00e3o Mundial de Sa\u00fade identificou claramente esta disparidade em 2025: Mesmo com uma r\u00e1pida expans\u00e3o da produ\u00e7\u00e3o, prev\u00ea-se que, at\u00e9 2030, menos de 10 % das pessoas potencialmente pass\u00edveis de tratamento tenham efetivamente acesso a estas subst\u00e2ncias. Uma <em>op\u00e7\u00e3o oral <\/em>eficaz e facilmente escal\u00e1vel n\u00e3o resolve, portanto, apenas uma quest\u00e3o de conforto, mas sim uma lacuna central na presta\u00e7\u00e3o de cuidados de sa\u00fade.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fterapias-orais-com-glp-1-attain-1-e-oasis-4-o-proximo-passo%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Os agonistas injet\u00e1veis do recetor do GLP-1 e o agonista duplo GIP\/GLP-1 tirzepatida redefiniram o tratamento farmacol\u00f3gico da obesidade e alcan\u00e7aram, em estudos, redu\u00e7\u00f5es de peso da ordem dos 15&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fterapias-orais-com-glp-1-attain-1-e-oasis-4-o-proximo-passo%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":560847,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Tratamento da obesidade","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11551,11397,11521,11524,11305,11403,11474],"tags":[95558,19681,95557,39386,15774],"powerkit_post_featured":[],"class_list":["post-560846","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-endocrinologia-e-diabetologia-2","category-estudos","category-formacao-continua","category-medicina-interna-geral","category-nutricao","category-prevencao-e-cuidados-de-saude","tag-attain-1","tag-bpl-1","tag-oasis-4","tag-peptide-pt-pt","tag-pequenas-moleculas","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-23 01:10:46","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":560849,"slug":"tratamientos-orales-con-glp-1-attain-1-y-oasis-4-el-siguiente-paso","post_title":"Tratamientos orales con GLP-1: ATTAIN-1 y OASIS-4: el siguiente paso","href":"https:\/\/medizinonline.com\/es\/tratamientos-orales-con-glp-1-attain-1-y-oasis-4-el-siguiente-paso\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/560846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=560846"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/560846\/revisions"}],"predecessor-version":[{"id":560848,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/560846\/revisions\/560848"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/560847"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=560846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=560846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=560846"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=560846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}